HIF1A and renal cell carcinoma: We did find, however, that auraptene decreased the half-life of HIF-1α protein in RCC cells, showing that, in the presence of cycloheximide to inhibit de novo protein synthesis, HIF-1α protein levels decreased more rapidly in the presence of auraptene (Fig. 5B, 5C).